talquetamab
janssen
['bet', 'lenalidomide', 'omg', 'daratumumab', 'fil,veral,12', 'teclistamab', 'alnuctamab', ' lena', 'talquetamab', 'marker ']
conclusions and summaries for the bispecifics presented at sat afternoon #ash2022 we have fda-approved teclistamab, but more are coming for #myeloma pts. talquetamab seems to be the farthest along. 
Myeloma since 1997. Retired from Family Practice after SCT. Cancer research advocate with NCI, Alliance, CIBMTR, FDA, many other areas.